Skip to menu Skip to content Skip to footer

2020

Conference Publication

Improving diagnosis and treatment of anxiety in Parkinson’s disease: IDATA-PD study update

Dissanayaka, N.N,, Byrne, G.J., Mitchell, L.K., O’Sullivan, J.D., Padmassini, A., White, E.X., Yang, J.H.J., Forbes, E., Thangavelu, K., Au, T., Lehn, A., Adams, R. and Pachana, N.A. (2020). Improving diagnosis and treatment of anxiety in Parkinson’s disease: IDATA-PD study update. MDS Virtual Congress 2020, Online, 12-16 September 2020.

Improving diagnosis and treatment of anxiety in Parkinson’s disease: IDATA-PD study update

2020

Conference Publication

Neural correlates of semantic fluency deficits in Parkinson's Disease with mild cognitive impairment

Yang, J., Copland, D., McMahon, K., Byrne, G., O'Sullivan, J. and Dissanayaka, N.N. (2020). Neural correlates of semantic fluency deficits in Parkinson's Disease with mild cognitive impairment. MDS Virtual Congress 2020, Online, 12-16 September 2020.

Neural correlates of semantic fluency deficits in Parkinson's Disease with mild cognitive impairment

2019

Journal Article

Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study

Sarris, Jerome, Byrne, Gerard J., Bousman, Chad A., Cribb, Lachlan, Savage, Karen M., Holmes, Oliver, Murphy, Jenifer, Macdonald, Patricia, Short, Anika, Nazareth, Sonia, Jennings, Emma, Thomas, Stuart, Ogden, Edward, Chamoli, Suneel, Scholey, Andrew and Stough, Con (2019). Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study. Australian and New Zealand Journal of Psychiatry, 54 (3), 000486741989124-297. doi: 10.1177/0004867419891246

Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study

2019

Journal Article

S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial

Sarris, Jerome, Murphy, Jenifer, Stough, Con, Mischoulon, David, Bousman, Chad, MacDonald, Patricia, Adams, Laura, Nazareth, Sonia, Oliver, Georgina, Cribb, Lachlan, Savage, Karen, Menon, Ranjit, Chamoli, Suneel, Berk, Michael, Ng, Chee H. and Byrne, Gerard J. (2019). S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial. Psychopharmacology, 237 (1), 209-218. doi: 10.1007/s00213-019-05358-1

S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial

2019

Journal Article

EPA and DHA as markers of nutraceutical treatment response in major depressive disorder

van der Burg, Kiki P., Cribb, Lachlan, Firth, Joseph, Karmacoska, Diana, Mischoulon, David, Byrne, Gerard J., Bousman, Chad, Stough, Con, Murphy, Jenifer, Oliver, Georgina, Berk, Michael, Ng, Chee H. and Sarris, Jerome (2019). EPA and DHA as markers of nutraceutical treatment response in major depressive disorder. European Journal of Nutrition, 59 (6), 2439-2447. doi: 10.1007/s00394-019-02090-6

EPA and DHA as markers of nutraceutical treatment response in major depressive disorder

2019

Journal Article

Delirium risk in non-surgical patients: systematic review of predictive tools

Dylan, Flaws, Byrne, Gerard and Mudge, Alison M (2019). Delirium risk in non-surgical patients: systematic review of predictive tools. Archives of Gerontology and Geriatrics, 83, 292-302. doi: 10.1016/j.archger.2019.05.013

Delirium risk in non-surgical patients: systematic review of predictive tools

2019

Journal Article

Takotsubo cardiomyopathy in the context of major neurocognitive disorder and multiple risk factors

Johnson, Jeremy C. S. and Byrne, Gerard J. A. (2019). Takotsubo cardiomyopathy in the context of major neurocognitive disorder and multiple risk factors. Swiss Archives of Neurology, Psychiatry and Psychotherapy, 170 (3) w03022. doi: 10.4414/sanp.2019.03022

Takotsubo cardiomyopathy in the context of major neurocognitive disorder and multiple risk factors

2019

Journal Article

L-theanine in the adjunctive treatment of generalized anxiety disorder: a double-blind, randomised, placebo-controlled trial

Sarris, Jerome, Byrne, Gerard J., Cribb, Lachlan, Oliver, Georgina, Murphy, Jenifer, Macdonald, Patricia, Nazareth, Sonia, Karamacoska, Diana, Galea, Samantha, Short, Anika, Ee, Carolyn, Birling, Yoann, Menon, Ranjit and Ng, Chee H. (2019). L-theanine in the adjunctive treatment of generalized anxiety disorder: a double-blind, randomised, placebo-controlled trial. Journal of Psychiatric Research, 110, 31-37. doi: 10.1016/j.jpsychires.2018.12.014

L-theanine in the adjunctive treatment of generalized anxiety disorder: a double-blind, randomised, placebo-controlled trial

2019

Journal Article

Depression symptomatology correlates with event-related potentials in Parkinson's disease: an affective priming study

Dissanayaka, Nadeeka N.W., Au, Tiffany R., Angwin, Anthony J., Iyer, Kartik K., O'Sullivan, John D., Byrne, Gerard J., Silburn, Peter A., Marsh, Rodney, Mellick, George D. and Copland, David A. (2019). Depression symptomatology correlates with event-related potentials in Parkinson's disease: an affective priming study. Journal of Affective Disorders, 245, 897-904. doi: 10.1016/j.jad.2018.11.094

Depression symptomatology correlates with event-related potentials in Parkinson's disease: an affective priming study

2019

Journal Article

Nutraceuticals for major depressive disorder- more is not merrier: an 8-week double-blind, randomised, controlled trial

Sarris, Jerome, Byrne, Gerard J, Stough, Con, Bousman, Chad, Mischoulon, David, Murphy, Jenifer, MacDonald, Patricia, Adams, Laura, Nazareth, Sonia, Oliver, Georgina, Cribb, Lachlan, Savage, Karen, Menon, Ranjit, Chamoli, Suneel, Berk, Michael and Ng, Chee (2019). Nutraceuticals for major depressive disorder- more is not merrier: an 8-week double-blind, randomised, controlled trial. Journal of Affective Disorders, 245, 1007-1015. doi: 10.1016/j.jad.2018.11.092

Nutraceuticals for major depressive disorder- more is not merrier: an 8-week double-blind, randomised, controlled trial

2019

Journal Article

QT-prolonging agents with risk of torsades de pointes

Johnson, Jeremy C. S. and Byrne, Gerard J. A. (2019). QT-prolonging agents with risk of torsades de pointes. Australasian Psychiatry, 27 (1), 92-92. doi: 10.1177/1039856218794875

QT-prolonging agents with risk of torsades de pointes

2019

Conference Publication

Broken heart syndrome (takotsubo cardiomyopathy) - what psychiatrists need to know: case report and review

Johnson, J. and Byrne, G. (2019). Broken heart syndrome (takotsubo cardiomyopathy) - what psychiatrists need to know: case report and review. RANZCP 2019 Congress, Cairns, Australia, 12-16 May, 2019. London, United Kingdom: Sage Publications. doi: 10.1177/0004867419836919

Broken heart syndrome (takotsubo cardiomyopathy) - what psychiatrists need to know: case report and review

2019

Conference Publication

Profiling atypical anxiety in Parkinson's disease

Forbes, E. J., Byrne, G. J., O'Sullivan, J. D., Yang, J. H. J., Marsh, R. and Dissanayaka, N. N. W. (2019). Profiling atypical anxiety in Parkinson's disease. University of Queensland Science Student Research Conference, Brisbane, QLD Australia, 12 October 2019.

Profiling atypical anxiety in Parkinson's disease

2019

Conference Publication

Identifying subtypes of Mild Cognitive Impairment in Parkinson’s Disease Using Cluster Analysis

Pourzinal, D., Yang, J., Byrne, G. J., O'Sullivan, J D., Mitchell, L., McMahon, K., Copland, D. A. and Dissanayaka, N. N. (2019). Identifying subtypes of Mild Cognitive Impairment in Parkinson’s Disease Using Cluster Analysis. International Congress of Parkinson’s Disease and Movement Disorders, Nice, France, 22-26 September 2019. Hoboken, NJ United States: John Wiley & Sons.

Identifying subtypes of Mild Cognitive Impairment in Parkinson’s Disease Using Cluster Analysis

2019

Conference Publication

Identifying altered resting-state network in Parkinson's disease with mild cognitive impairment

Yang, J. H., McMahon, K. L., Copland, D. A., Byrne, G. J., Mitchell, L. K., O'Sullivan, J. D. and Dissanayaka, N. N. W. (2019). Identifying altered resting-state network in Parkinson's disease with mild cognitive impairment. 23rd Annual Meeting of the Organisation for Human Brain Mapping, Rome, Italy, 9-13 June 2019.

Identifying altered resting-state network in Parkinson's disease with mild cognitive impairment

2019

Conference Publication

Assessment of anxiety in the presence of dementia

Byrne, G. J., Arnold, E. and Pachana, N. A. (2019). Assessment of anxiety in the presence of dementia. RANZCP 2019 Congress, Cairns, QLD Australia, 12-16 May 2019. London, United Kingdom: Sage.

Assessment of anxiety in the presence of dementia

2019

Conference Publication

Identifying Altered Resting-State Networks in Parkinson’s disease Patients with Mild Cognitive Impairment

Yang, J., McMahon, K., Copland, D. A., Byrne, G. J., O'Sullivan, J. D., Mitchell, L. and Dissanayaka, N. N. (2019). Identifying Altered Resting-State Networks in Parkinson’s disease Patients with Mild Cognitive Impairment. International Congress of Parkinson’s Disease and Movement Disorders, Nice, France, 22-26 September 2019. Hoboken, NJ United States: John Wiley & Sons.

Identifying Altered Resting-State Networks in Parkinson’s disease Patients with Mild Cognitive Impairment

2019

Conference Publication

A balanced mental health score card for residential aged care: development and validation

Brimelow, R., Byrne, G., Beattie, E. and Dissanayaka, N. (2019). A balanced mental health score card for residential aged care: development and validation. NHMRC National Institute for Dementia Research Australian Dementia Forum, Hobart, Tasmania, 13-14 June 2019.

A balanced mental health score card for residential aged care: development and validation

2018

Journal Article

Prescribing of psychotropic drugs and indicators for use in residential aged care and residents with dementia

Brimelow, R. E., Wollin, J. A., Byrne, G. J. and Dissanayaka, N. N. (2018). Prescribing of psychotropic drugs and indicators for use in residential aged care and residents with dementia. International Psychogeriatrics, 31 (06), 1-11. doi: 10.1017/s1041610218001229

Prescribing of psychotropic drugs and indicators for use in residential aged care and residents with dementia

2018

Journal Article

Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: an 8-week double-blind, randomized, controlled trial

Sarris, Jerome, Byrne, Gerard J., Bousman, Chad, Stough, Con, Murphy, Jenifer, MacDonald, Patricia, Adams, Laura, Nazareth, Sonia, Oliver, Georgina, Cribb, Lachlan, Savage, Karen, Menon, Ranjit, Chamoli, Suneel, Berk, Michael, Ng, Chee and Mischoulon, David (2018). Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: an 8-week double-blind, randomized, controlled trial. European Neuropsychopharmacology, 28 (10), 1126-1136. doi: 10.1016/j.euroneuro.2018.07.098

Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: an 8-week double-blind, randomized, controlled trial